DRES-07. TMZ-LEV- IFN COCKTAIL REGIMEN SIGNIFICANTLY INHIBITED THE GROWTH OF GLIOMA IN VIVO

OBJECTIVE: Temozolomide (TMZ), is the first line chemotherapeutic drug for glioma. Previous studies have suggested that interferon (IFN) and levetiracetam (LEV) could respectively reverse the resistance of TMZ by down-regulating MGMT expression. This study, we aim to investigate the therapeutic effe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Ni, Xiang-rong, Wang, Jing, Chen, Fu-rong, Cai, Hai-ping, Yu, Yan-jiao, Yang, Qun-ying, Guo, Chengcheng, Chen, Zhong-ping, Qu, Yue
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Drug Resistance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847639/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.295
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares